4//SEC Filing
Chanda Sanjay 4
Accession 0001610717-24-000166
CIK 0001880438other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 7:27 PM ET
Size
7.1 KB
Accession
0001610717-24-000166
Insider Transaction Report
Form 4
Chanda Sanjay
Chief Development Officer
Transactions
- Award
Common Stock
2024-03-15+27,500→ 28,235 total - Award
Stock Option (right to buy)
2024-03-15+55,000→ 55,000 totalExercise: $3.00Exp: 2034-03-14→ Common Stock (55,000 underlying)
Footnotes (3)
- [F1]These restricted stock units vest as follows: 1/16th of the shares vests quarterly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
- [F2]Reflects the adjusted total which includes the purchase of 735 shares under the AN2 Therapeutics, Inc. 2022 Employee Stock Purchase Plan on September 29, 2023.
- [F3]The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001571820
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 7:27 PM ET
- Size
- 7.1 KB